1.
Front Immunol
; 13: 900522, 2022.
Article
in English
| MEDLINE | ID: covidwho-1903024
ABSTRACT
Invasive fungal diseases (IFD) still cause substantial morbidity and mortality, and new therapeutic approaches are urgently needed. Recent data suggest a benefit of checkpoint inhibitors (ICI). We report the case of a diabetic patient with refractory IFD following a SARSCoV-2 infection treated by ICI and interferon-gamma associated with antifungal treatment.